Review



total antibodies s protein trimer  (VECTOR-BEST)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    VECTOR-BEST total antibodies s protein trimer
    Anti-SARS-CoV-2 antibody levels following immunization of 27 randomly selected participants who were seronegative at screening. nAB titers in NT (A); and positivity coefficients for ELISA and CMIA kits: <t>anti-S</t> trimer total antibodies ELISA (Vector-Best) <t>(B);</t> <t>anti-RBD</t> total antibodies ELISA (CoronaPass) (C); anti-RBD IgG CMIA (Beckman) (D); and anti-N IgG CMIA (Abbot) (E). Black line – Mean, whiskers – SD. Blue area signifies a positive threshold (grey zone) for each test. Black dots represent the results from sera samples from 6 randomly selected participants from Placebo Group obtained in the same tests in parallel (with Vector-Best sera from 3 participants were tested). Purple dots represent 4 samples of convalescent sera used as positive controls.
    Total Antibodies S Protein Trimer, supplied by VECTOR-BEST, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/total+antibodies+s+protein+trimer/total+antibodies+s+protein+trimer/med_rxiv__2022__02__08__22270658-44-26-29
    Average 90 stars, based on 1 article reviews
    total antibodies s protein trimer - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "Safety and immunogenicity of inactivated whole virion vaccine CoviVac against COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase I/II clinical trial"

    Article Title: Safety and immunogenicity of inactivated whole virion vaccine CoviVac against COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase I/II clinical trial

    Journal: medRxiv

    doi: 10.1101/2022.02.08.22270658

    Anti-SARS-CoV-2 antibody levels following immunization of 27 randomly selected participants who were seronegative at screening. nAB titers in NT (A); and positivity coefficients for ELISA and CMIA kits: anti-S trimer total antibodies ELISA (Vector-Best) (B); anti-RBD total antibodies ELISA (CoronaPass) (C); anti-RBD IgG CMIA (Beckman) (D); and anti-N IgG CMIA (Abbot) (E). Black line – Mean, whiskers – SD. Blue area signifies a positive threshold (grey zone) for each test. Black dots represent the results from sera samples from 6 randomly selected participants from Placebo Group obtained in the same tests in parallel (with Vector-Best sera from 3 participants were tested). Purple dots represent 4 samples of convalescent sera used as positive controls.
    Figure Legend Snippet: Anti-SARS-CoV-2 antibody levels following immunization of 27 randomly selected participants who were seronegative at screening. nAB titers in NT (A); and positivity coefficients for ELISA and CMIA kits: anti-S trimer total antibodies ELISA (Vector-Best) (B); anti-RBD total antibodies ELISA (CoronaPass) (C); anti-RBD IgG CMIA (Beckman) (D); and anti-N IgG CMIA (Abbot) (E). Black line – Mean, whiskers – SD. Blue area signifies a positive threshold (grey zone) for each test. Black dots represent the results from sera samples from 6 randomly selected participants from Placebo Group obtained in the same tests in parallel (with Vector-Best sera from 3 participants were tested). Purple dots represent 4 samples of convalescent sera used as positive controls.

    Techniques Used: Enzyme-linked Immunosorbent Assay, Plasmid Preparation

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: Safety and immunogenicity of inactivated whole virion vaccine CoviVac against COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase I/II clinical trial
    Article Snippet: IgG antibodies to receptor-binding domain (RBD) of the spike protein (S) were detected using Access SARS-CoV-2 IgG CMIA (Beckman, USA). .. Serum samples from randomly selected participants were additionally tested in ELISA for total antibodies against RBD with CoronaPass Total (Genetico, Russia) and for total antibodies to S protein trimer (Vector-Best, Russia). ..



    Similar Products

    total antibodies s protein trimer  (VECTOR-BEST)
    90
    VECTOR-BEST total antibodies s protein trimer
    Anti-SARS-CoV-2 antibody levels following immunization of 27 randomly selected participants who were seronegative at screening. nAB titers in NT (A); and positivity coefficients for ELISA and CMIA kits: <t>anti-S</t> trimer total antibodies ELISA (Vector-Best) <t>(B);</t> <t>anti-RBD</t> total antibodies ELISA (CoronaPass) (C); anti-RBD IgG CMIA (Beckman) (D); and anti-N IgG CMIA (Abbot) (E). Black line – Mean, whiskers – SD. Blue area signifies a positive threshold (grey zone) for each test. Black dots represent the results from sera samples from 6 randomly selected participants from Placebo Group obtained in the same tests in parallel (with Vector-Best sera from 3 participants were tested). Purple dots represent 4 samples of convalescent sera used as positive controls.
    Total Antibodies S Protein Trimer, supplied by VECTOR-BEST, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/total+antibodies+s+protein+trimer/total+antibodies+s+protein+trimer/med_rxiv__2022__02__08__22270658-44-26-29
    Average 90 stars, based on 1 article reviews
    total antibodies s protein trimer - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Anti-SARS-CoV-2 antibody levels following immunization of 27 randomly selected participants who were seronegative at screening. nAB titers in NT (A); and positivity coefficients for ELISA and CMIA kits: anti-S trimer total antibodies ELISA (Vector-Best) (B); anti-RBD total antibodies ELISA (CoronaPass) (C); anti-RBD IgG CMIA (Beckman) (D); and anti-N IgG CMIA (Abbot) (E). Black line – Mean, whiskers – SD. Blue area signifies a positive threshold (grey zone) for each test. Black dots represent the results from sera samples from 6 randomly selected participants from Placebo Group obtained in the same tests in parallel (with Vector-Best sera from 3 participants were tested). Purple dots represent 4 samples of convalescent sera used as positive controls.

    Journal: medRxiv

    Article Title: Safety and immunogenicity of inactivated whole virion vaccine CoviVac against COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase I/II clinical trial

    doi: 10.1101/2022.02.08.22270658

    Figure Lengend Snippet: Anti-SARS-CoV-2 antibody levels following immunization of 27 randomly selected participants who were seronegative at screening. nAB titers in NT (A); and positivity coefficients for ELISA and CMIA kits: anti-S trimer total antibodies ELISA (Vector-Best) (B); anti-RBD total antibodies ELISA (CoronaPass) (C); anti-RBD IgG CMIA (Beckman) (D); and anti-N IgG CMIA (Abbot) (E). Black line – Mean, whiskers – SD. Blue area signifies a positive threshold (grey zone) for each test. Black dots represent the results from sera samples from 6 randomly selected participants from Placebo Group obtained in the same tests in parallel (with Vector-Best sera from 3 participants were tested). Purple dots represent 4 samples of convalescent sera used as positive controls.

    Article Snippet: Serum samples from randomly selected participants were additionally tested in ELISA for total antibodies against RBD with CoronaPass Total (Genetico, Russia) and for total antibodies to S protein trimer (Vector-Best, Russia).

    Techniques: Enzyme-linked Immunosorbent Assay, Plasmid Preparation